These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

171 related articles for article (PubMed ID: 31625212)

  • 1. The requirement of SUMO2/3 for SENP2 mediated extraembryonic and embryonic development.
    Yu HI; Hsu T; Maruyama EO; Paschen W; Yang W; Hsu W
    Dev Dyn; 2020 Feb; 249(2):237-244. PubMed ID: 31625212
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Extraembryonic but not embryonic SUMO-specific protease 2 is required for heart development.
    Maruyama EO; Lin H; Chiu SY; Yu HM; Porter GA; Hsu W
    Sci Rep; 2016 Feb; 6():20999. PubMed ID: 26883797
    [TBL] [Abstract][Full Text] [Related]  

  • 3. SUMO2 is essential while SUMO3 is dispensable for mouse embryonic development.
    Wang L; Wansleeben C; Zhao S; Miao P; Paschen W; Yang W
    EMBO Rep; 2014 Aug; 15(8):878-85. PubMed ID: 24891386
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Senp1 is essential for desumoylating Sumo1-modified proteins but dispensable for Sumo2 and Sumo3 deconjugation in the mouse embryo.
    Sharma P; Yamada S; Lualdi M; Dasso M; Kuehn MR
    Cell Rep; 2013 May; 3(5):1640-50. PubMed ID: 23684609
    [TBL] [Abstract][Full Text] [Related]  

  • 5. SUMO-specific protease 2 is essential for modulating p53-Mdm2 in development of trophoblast stem cell niches and lineages.
    Chiu SY; Asai N; Costantini F; Hsu W
    PLoS Biol; 2008 Dec; 6(12):e310. PubMed ID: 19090619
    [TBL] [Abstract][Full Text] [Related]  

  • 6. SUMO-specific protease 2 in Mdm2-mediated regulation of p53.
    Jiang M; Chiu SY; Hsu W
    Cell Death Differ; 2011 Jun; 18(6):1005-15. PubMed ID: 21183956
    [TBL] [Abstract][Full Text] [Related]  

  • 7. SUMO-specific protease 2 is essential for suppression of polycomb group protein-mediated gene silencing during embryonic development.
    Kang X; Qi Y; Zuo Y; Wang Q; Zou Y; Schwartz RJ; Cheng J; Yeh ET
    Mol Cell; 2010 Apr; 38(2):191-201. PubMed ID: 20417598
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Loss of SUMO1 in mice affects RanGAP1 localization and formation of PML nuclear bodies, but is not lethal as it can be compensated by SUMO2 or SUMO3.
    Evdokimov E; Sharma P; Lockett SJ; Lualdi M; Kuehn MR
    J Cell Sci; 2008 Dec; 121(Pt 24):4106-13. PubMed ID: 19033381
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Engineering pre-SUMO4 as efficient substrate of SENP2.
    Liu Y; Kieslich CA; Morikis D; Liao J
    Protein Eng Des Sel; 2014 Apr; 27(4):117-26. PubMed ID: 24671712
    [TBL] [Abstract][Full Text] [Related]  

  • 10. SUMO2 and SUMO3 transcription is differentially regulated by oxidative stress in an Sp1-dependent manner.
    Sang J; Yang K; Sun Y; Han Y; Cang H; Chen Y; Shi G; Wang K; Zhou J; Wang X; Yi J
    Biochem J; 2011 Apr; 435(2):489-98. PubMed ID: 21291420
    [TBL] [Abstract][Full Text] [Related]  

  • 11. An essential role of small ubiquitin-like modifier (SUMO)-specific Protease 2 in myostatin expression and myogenesis.
    Qi Y; Zuo Y; Yeh ET; Cheng J
    J Biol Chem; 2014 Feb; 289(6):3288-93. PubMed ID: 24344126
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Dynamic regulation of HIF1Α stability by SUMO2/3 and SENP3 in the human placenta.
    Bhattacharjee J; Alahari S; Sallais J; Tagliaferro A; Post M; Caniggia I
    Placenta; 2016 Apr; 40():8-17. PubMed ID: 27016777
    [TBL] [Abstract][Full Text] [Related]  

  • 13. SENP3 regulates the global protein turnover and the Sp1 level via antagonizing SUMO2/3-targeted ubiquitination and degradation.
    Wang M; Sang J; Ren Y; Liu K; Liu X; Zhang J; Wang H; Wang J; Orian A; Yang J; Yi J
    Protein Cell; 2016 Jan; 7(1):63-77. PubMed ID: 26511642
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Structure of the human SENP7 catalytic domain and poly-SUMO deconjugation activities for SENP6 and SENP7.
    Lima CD; Reverter D
    J Biol Chem; 2008 Nov; 283(46):32045-55. PubMed ID: 18799455
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Structural insights into the SENP6 Loop1 structure in complex with SUMO2.
    Alegre KO; Reverter D
    Protein Sci; 2014 Apr; 23(4):433-41. PubMed ID: 24424631
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Enhanced desumoylation in murine hearts by overexpressed SENP2 leads to congenital heart defects and cardiac dysfunction.
    Kim EY; Chen L; Ma Y; Yu W; Chang J; Moskowitz IP; Wang J
    J Mol Cell Cardiol; 2012 Mar; 52(3):638-49. PubMed ID: 22155005
    [TBL] [Abstract][Full Text] [Related]  

  • 17. RanBP2 and SENP3 function in a mitotic SUMO2/3 conjugation-deconjugation cycle on Borealin.
    Klein UR; Haindl M; Nigg EA; Muller S
    Mol Biol Cell; 2009 Jan; 20(1):410-8. PubMed ID: 18946085
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Small ubiquitin-like modifier 3-modified proteome regulated by brain ischemia in novel small ubiquitin-like modifier transgenic mice: putative protective proteins/pathways.
    Yang W; Sheng H; Thompson JW; Zhao S; Wang L; Miao P; Liu X; Moseley MA; Paschen W
    Stroke; 2014 Apr; 45(4):1115-22. PubMed ID: 24569813
    [TBL] [Abstract][Full Text] [Related]  

  • 19. SUMO2 and SUMO3 redundantly prevent a noncanonical type I interferon response.
    Crowl JT; Stetson DB
    Proc Natl Acad Sci U S A; 2018 Jun; 115(26):6798-6803. PubMed ID: 29891701
    [TBL] [Abstract][Full Text] [Related]  

  • 20. SENP2 negatively regulates cellular antiviral response by deSUMOylating IRF3 and conditioning it for ubiquitination and degradation.
    Ran Y; Liu TT; Zhou Q; Li S; Mao AP; Li Y; Liu LJ; Cheng JK; Shu HB
    J Mol Cell Biol; 2011 Oct; 3(5):283-92. PubMed ID: 22028379
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.